There is some interesting insight offered by the CEO presentation to the AGM today.
A year ago the board was advised they could get $6/share so they embarked on a sale process. They ended up rejecting the offer and it has had the effect to divert management attention in the year after they had a major expansion into Europe and it will impact this years result. They will announce the impact with the 1st half results in Feb.
From the transcript.
NBIO Process
As announced, the Company has experienced inbound interest in a variety of corporate transactions over recent years. About a year ago the Board formed a view following advice from advisers that we could conduct a successful sale at or about $6.00 per share. Therefore, we embarked upon a sale process. The process, which was all consuming for our small group of executives and the Board, was undertaken while the company embarked upon our innovative expansion of our global offering of our SAS business in the northern and southern hemispheres.
The result of the sale process was disappointing with an offer emerging of $5.15, rejected by the Board last month.
Looking forward
The distraction of management time from running the business to dealing with due diligence etc. was very costly and the outcome was further impacted by the hacking which took place during August due to the need to protect the customer and employee data and manage the Company’s response. Now, with certain changes to management, we have resumed normal business.
The distraction of the sale process and set-back will have adverse consequences for this years result compared to our initial budget but the Board has confidence in its core management and market position. We will resume the previous upward trajectory, the benefits of which will continue to become apparent over the next 12 months. The timing of the attempted sale was unfortunate and costly with the consequence that there will be no dividend for 2023.
The Board will consider providing an FY24 outlook after the release of the 2024 1H results in February.